UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Capital Advisors Wealth Management LLC

Capital Advisors Wealth Management LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 8.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,773 shares of the healthcare conglomerate’s stock after purchasing an additional 135 shares during the period. Capital Advisors Wealth Management LLC’s holdings in UnitedHealth Group were worth $852,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in UNH. Chesapeake Wealth Management boosted its holdings in shares of UnitedHealth Group by 7.0% during the fourth quarter. Chesapeake Wealth Management now owns 4,992 shares of the healthcare conglomerate’s stock worth $2,647,000 after purchasing an additional 326 shares during the period. Westhampton Capital LLC boosted its holdings in shares of UnitedHealth Group by 1.2% during the first quarter. Westhampton Capital LLC now owns 2,587 shares of the healthcare conglomerate’s stock worth $1,223,000 after purchasing an additional 30 shares during the period. Two Sigma Investments LP acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $87,114,000. Sendero Wealth Management LLC lifted its stake in UnitedHealth Group by 10.8% in the first quarter. Sendero Wealth Management LLC now owns 6,210 shares of the healthcare conglomerate’s stock valued at $2,935,000 after acquiring an additional 607 shares during the last quarter. Finally, Alta Capital Management LLC raised its position in shares of UnitedHealth Group by 335.1% in the first quarter. Alta Capital Management LLC now owns 62,712 shares of the healthcare conglomerate’s stock valued at $29,637,000 after purchasing an additional 48,300 shares during the period. 85.69% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 0.1 %

Shares of UnitedHealth Group stock opened at $486.06 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $558.10. The business has a 50-day moving average of $492.05 and a two-hundred day moving average of $486.73. The company has a market capitalization of $450.24 billion, a P/E ratio of 21.75, a price-to-earnings-growth ratio of 1.43 and a beta of 0.66. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.80 and a quick ratio of 0.80.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.92 by $0.22. UnitedHealth Group had a net margin of 6.06% and a return on equity of 26.72%. The company had revenue of $92.90 billion for the quarter, compared to the consensus estimate of $90.97 billion. During the same period last year, the company earned $5.57 earnings per share. The firm’s revenue was up 15.6% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 24.83 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Monday, September 11th will be issued a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date of this dividend is Friday, September 8th. UnitedHealth Group’s payout ratio is presently 33.65%.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Andrew Witty sold 4,000 shares of the stock in a transaction dated Wednesday, July 19th. The shares were sold at an average price of $506.19, for a total value of $2,024,760.00. Following the transaction, the chief executive officer now directly owns 78,573 shares of the company’s stock, valued at approximately $39,772,866.87. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.35% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. JPMorgan Chase & Co. lifted their price target on shares of UnitedHealth Group from $527.00 to $532.00 and gave the company an “overweight” rating in a research report on Monday, July 17th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of UnitedHealth Group from $564.00 to $555.00 in a research report on Monday, July 17th. StockNews.com initiated coverage on shares of UnitedHealth Group in a research report on Thursday, August 17th. They set a “buy” rating on the stock. Morgan Stanley reaffirmed an “overweight” rating and set a $587.00 target price on shares of UnitedHealth Group in a research report on Friday, July 14th. Finally, Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $616.00 to $561.00 in a research report on Thursday, July 13th. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $575.65.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.